Ebbing Lautenbach, MD, MPH, MSCE
Dr. Lautenbach's research focuses on antibiotic use, antimicrobial resistance, outbreak investigation and epidemiologic methods in the study of infectious diseases. This research focuses on various healthcare settings, including acute care hospitals and long term care facilities. Dr. Lautenbach investigates the emergence and impact of extended-spectrum beta-lactamase (ESBL) resistance among gram-negative organisms, particularly how the dissemination of this resistance mechanism responds to manipulations of hospital antimicrobial formularies. He also studies patterns of use of the fluoroquinolone antibiotics, as well as how such use patterns affect current trends in resistance to these agents. Finally, Dr. Lautenbach studies the epidemiology and transmission of methicillin-resistant Staphylococcus aureus (MRSA) in the community.
Infectious diseases, patient-oriented research, pharmacoepidemiology, public health
Categorical data, multivariate analysis